Browse > Article

Stimulation of the Immune Response by Yanggyuksanhwa-tang  

Jung, Da-Young (Herbal Medicine EBM Research Center, Korea Institute of Oriental Medicine)
Ha, Hye-Kyung (Herbal Medicine EBM Research Center, Korea Institute of Oriental Medicine)
Lee, Ho-Young (Herbal Medicine EBM Research Center, Korea Institute of Oriental Medicine)
Lee, Jin-Ah (Herbal Medicine EBM Research Center, Korea Institute of Oriental Medicine)
Lee, Nam-Hun (Herbal Medicine EBM Research Center, Korea Institute of Oriental Medicine)
Lee, Jun-Kyoung (Herbal Medicine EBM Research Center, Korea Institute of Oriental Medicine)
Huang, Dae-Sun (Herbal Medicine EBM Research Center, Korea Institute of Oriental Medicine)
Shin, Hyeun-Kyoo (Herbal Medicine EBM Research Center, Korea Institute of Oriental Medicine)
Publication Information
Journal of Sasang Constitutional Medicine / v.22, no.4, 2010 , pp. 77-84 More about this Journal
Abstract
1. Objectives Yanggyuksanhwa-tang for Soyangin was applied to investigate the immunological activities on antigen (Ag)-specific or Ag-non-specific immune responses on murine macrophage cell line (RAW 264.7) and ovalbumin/aluminium (OVA/Alum)-immunized mice. 2. Methods This study were carried out in nitric oxide (NO) synthesis on RAW 264.7 cells and cellular proliferation on mouse splenocytes. C57BL/6 mice were immunized intraperitonially with OVA/Alum (100 ${\mu}g$/200 ${\mu}g$) on day 1, 8, and 15. Yanggyuksanhwa-tang was administrated to mice orally for 3 weeks from day 1. On day 22, OVA-, lipopolysaccharide (LPS)-, and concanavalin A (Con A)-stimulated splenocyte proliferation and antibodies (OVA-specific antibodies of the IgG, IgG1, and total IgM classes) in plasma were measured. 3. Results Yanggyuksanhwa-tang significantly enhanced cellular proliferation by LPS and Con A on splenocytes from OVA/Alum-immunized mice (p<.001). Yanggyuksanhwa-tang also significantly enhanced plasma OVA-specific IgG (p<.001), IgG1 (p<.001), and total IgM (p<.01) levels compared with the OVA/Alum group. 4. Conclusions These results suggested that Yanggyuksanhwa-tang for Soyangin could be used as immunopotent.
Keywords
Yanggyuksanhwa-tang (Lianggesanhuo-tang); Antibodies; LPS; Con A; OVA;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 Cho SW. Effects of Yangkyuksanhawtang on the allergic contact dermatitis. Korean Journal of Korean Medical Institute of Dermatology & Aesthetics. 2005;1(1):16-40. (Korean)
2 Soh YJ. Protective effect of Yangguksanwha-tang metabolized by liver homogenate on hypoxia-reperfusion induced PC12 cell damage. Yakhak Hoeji. 2005;49(1):97-102. (Korean)   과학기술학회마을
3 Son SK, Shin MG, Song IB. Effects of Yanggyuksanhwatang on cerebral blood flow and Ischemic brain damage in rats. J Sasang Constitut Med. 2001;13(2):165-176. (Korean)
4 Boo IG, Kim YS. Immunohistochemical study of Yanggyuksanhwa-tang on focal cerebral ischemia of diabetic rats. Korea J Oriental Physiology & Pathology. 2007;21(3):741-747.(Korean),   과학기술학회마을
5 Lee JM. Dongeuisusebowon. Seoul:Yeogang Publishing Co. 1992:243-271.(Korean)
6 Lee JM. Dongeuisusebowon. Seoul:Shinil Publishing Co. 1964:70.(Korean)
7 Kim KY. The approach of Sasang constitutional medicine in incurable disease and immunity. J Sasang Constitut Med. 1995;7(2):113-128.(Korean)
8 Choi AY, Ha JH, Lee JH, Jang WS, Goo DM. A clinical study on strabismus patient of abducence nerve paralysis in Soyangin improved with Yangkyuksanhwa-tang. J Sasang Constitut Med. 2008;20 (3):176-183.(Korean)   과학기술학회마을
9 Lo HS, Lee SM, Bae YC, Park HS, Lee JS, Song SG, et al. The Effect of Yangkyuksanhwa-tang on cytokine production in the patients with cerebral infarction J Sasang Constitut Med. 2004;16(1):120-129. (Korean)
10 Choi DJ, Ryu SH, Jung WS, Moon SK, Cho KH, Kim YS. The clinical efficacy of Yangkyuksanwha-tang on acute stroke. J Korean Oriental Med. 2004;25(1):111-116.(Korean)   과학기술학회마을
11 Yun BH, Park SS. Yangkyuksanhwa-tang effected to atopic dermatitis. J Sasang Constitut Med. 2004;16(2):84-98.(Korean)
12 Zalys R, Zagon IS, Bonneau RH, Lang CM, McLaughlin PJ. In vivo effect of chronic treatment with (MET5)-en-kephain on hematological values and natural killer cell activity in athymic mice. Life Sci. 2000;66:829-834.   DOI   ScienceOn
13 James GL. Methods in Immunotoxicology. John Wiley-Liss, Inc, San Diego. 1995;2-15.
14 Liew FY, Lia Y, Millot S. Tumor necrosis factor synergizes with IFN-$\gamma$ in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol. 1990;145:4306-4310.
15 Thornberry NA, Molineaux SX. Interleukin-1 beta converting enzyme: a novel cystein protease required for IL-1 beta production and implicated in progammed cell death. Protein Sci. 2005;4:3-12.
16 Burger D, Dayer JM, Palmer G, Gabay C. Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract Clin Rheumatol. 2006;20(5):879-896.   DOI   ScienceOn
17 Sung CS, Wong CS. Cellular mechanisms of neuroinflammatory pain: the role of interleukin-1beta. Act Anaesthsiol Taiwan. 2007;45(2):103-109.
18 Weiss L. Cell and tissue biology 6th ed. Uraban & Schwarzenbeg. Baltimore. 1988;481-538.
19 Kim EJ, Kim YS. Effects of Yanggyuksanhwa-tang on global cerebral ischemia of diabetic rats induced by streptozotocin. Korea J Oriental Physiology & Pathology. 2007;21(2):474-478.(Korean)
20 Lee SY, Choi AY, Ha JH, Lee JH, Kim PJ, Goo DM. An experimental study on the anti-stress effect by Soyangin Hyeongbangdojeok-san and Yanggyeoksanhwa-tang. J Sasang Constitut Med. 2008;20(3): 151-163.(Korean)   과학기술학회마을
21 Jung SI, Kim JW. Clinical study about the diabetes mellitus patients administration of Yangkyuksanwhatang. Korea J Oriental Physiology & Pathology. 2002;16(6):1308-1313. (Korean)   과학기술학회마을
22 Kim SJ, Kim MS, Seo BI, Gu DM, Seo HY, An HD. One case report of urinary and bowel dysfunction treated with Yangkyuksanwha-tang in cerebrovascular accident patient. Kor J Herbology. 2003;18(3):1-8.(Korean)   과학기술학회마을